Product NDC: | 0173-0814 |
Proprietary Name: | POTIGA |
Non Proprietary Name: | ezogabine |
Active Ingredient(s): | 400 mg/1 & nbsp; ezogabine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0814 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022345 |
Marketing Category: | NDA |
Start Marketing Date: | 20120419 |
Package NDC: | 0173-0814-59 |
Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (0173-0814-59) |
NDC Code | 0173-0814-59 |
Proprietary Name | POTIGA |
Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (0173-0814-59) |
Product NDC | 0173-0814 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ezogabine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120419 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | EZOGABINE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Potassium Channel Openers [MoA],Potassium Channel Opener [EPC] |